Literature DB >> 24761926

Multicenter epidemiologic study on hepatocellular carcinoma in Turkey.

Alper Can1, Erkan Dogan, Ibrahim Vedat Bayoglu, Ali Murat Tatli, Mehmet Besiroglu, Murat Kocer, Ahmet Cumhur Dulger, Ummugul Uyeturk, Derya Kivrak, Zuat Orakci, Oznur Bal, Turgut Kacan, Sehmus Olmez, Nedim Turan, Mehmet Fatih Ozbay, Ahmet Alacacioglu.   

Abstract

BACKGROUND: Hepatocellular cancer (HCC) is one of the important health problems in Turkey, being very common and highly lethal. The aim of this study was to determine clinical, demographic features and risk factors.
MATERIALS AND METHODS: Nine hundred and sixth-three patients with HCC from 13 cities in Turkey were included in this study.
RESULTS: Only 205 (21%) of the 963 patients were women, with a male:female predominance of 4.8:1 and a median age of 61 years. The etiologic risk factors for HCC were hepatitis B in 555 patients (57.6%), 453 (81%) in men, and 102 (19%) in women, again with male predominance, hepatitis C in 159 (16.5%), (14.9% and 22.4%, with a higher incidence in women), and chronic alcohol abuse (more than ten years) in 137 (14.2%) (16.8% and 4.9%, higher in males). The Child-Pugh score paralleled with advanced disease stage amd also a high level of AFP.
CONCLUSIONS: According to our findings the viral etiology (hepatitis B and hepatitis C infections) in the Turkish population was the most important factor in HCC development, with alcohol abuse as the third risk factor. The Child-Pugh classification and AFP levels were determined to be important prognostic factors in HCC patients.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24761926     DOI: 10.7314/apjcp.2014.15.6.2923

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  8 in total

1.  Wide Sexual Dimorphism of Hepatocellular Carcinoma Presentation in Algeria.

Authors:  Yazid Chikhi; Salima Cheraitia; Rachid Ould Gougam; Fadila Lounes; Chahrazed Zemmouchi; Nassila Belal; Maroua Bendaoud; Sonia Ait Younes; Aicha Bensalem; Saadi Berkane; Hocine Asselah; Pascal Pineau; Mustapha Lahcene
Journal:  Gastrointest Tumors       Date:  2019-08-30

2.  Baseline characteristics associated with survival in patients with hepatocellular carcinoma.

Authors:  Seymur Aslanov; Nalan Gulsen Unal; Ali Senkaya; Ferit Celik; Abdullah Murat Buyruk; Alper Uysal; Murat Akyildiz; Ilker Turan; Fulya Gunsar; Galip Ersoz; Abdullah Zeki Karasu; Ahmet Omer Ozutemiz; Ulus Salih Akarca
Journal:  Hepatol Forum       Date:  2021-12-05

3.  Prevalence of K-Ras mutations in hepatocellular carcinoma: A Turkish Oncology Group pilot study.

Authors:  Nazim Serdar Turhal; Berna Savaş; Öznur Çoşkun; Emine Baş; Bülent Karabulut; Deniz Nart; Taner Korkmaz; Dilek Yavuzer; Gökhan Demir; Gülen Doğusoy; Mehmet Artaç
Journal:  Mol Clin Oncol       Date:  2015-08-31

4.  Risk and prognostic nomograms for hepatocellular carcinoma with newly-diagnosed pulmonary metastasis using SEER data.

Authors:  Guanzhi Ye; Lin Wang; Zhengyang Hu; Jiaqi Liang; Yunyi Bian; Cheng Zhan; Zongwu Lin
Journal:  PeerJ       Date:  2019-08-16       Impact factor: 2.984

5.  Characteristics of patients with hepatocellular carcinoma: A multicenter study.

Authors:  Fatih Guzelbulut; Umit Karaogullarindan; Hikmet Akkiz; Engin Altintas; Coskun Ozer Demirtas; Ozgur Bahadir; Caglayan Keklikkiran; Abdullah Emre Yildirim; Mesut Gumussoy; Hatice Rizaoglu Balci; Pinar Gokcen; Dilara Turan Gokce; Cem Simsek; Ilker Turan; Guray Can; Volkan Gokbulut; Serkan Yaras; Gupse Adali; Remzi Adnan Akdogan; Ufuk Avcioglu; Mehmet Demir; Hamdi Levent Doganay; Sezgin Vatansever; Hale Sumer; Feyza Dilber; Meral Akdogan Kayhan; Hatice Yasemin Balaban; Halis Simsek; Osman Cavit Ozdogan; Ulus Salih Akarca; Zeki Karasu; Fulya Gunsar; Ramazan Idilman
Journal:  Hepatol Forum       Date:  2022-09-23

6.  Effect of Tetanus-diphtheria Vaccine on Immune Response to Hepatitis B Vaccine in Low-responder Individuals.

Authors:  Abbas Haghighat; Mohammad Moafi; Jalil Sharifian; Hassan Salehi; Roya Taleban; Nader Kalbasi; Marzieh Salehi; Mohammad Mahdi Salehi; Maryam Salehi
Journal:  Int J Prev Med       Date:  2016-07-21

7.  Diagnostic Dilemma for Low Viremia with Significant Fibrosis; is Hepatitis B Virus DNA Threshold Level a Good Indicator for Predicting Liver Damage?

Authors:  Ercan Yenilmez; Rıza Aytaç Çetinkaya; Ersin Tural
Journal:  Balkan Med J       Date:  2018-05-04       Impact factor: 2.021

8.  MicroRNA-214-3p inhibits proliferation and cell cycle progression by targeting MELK in hepatocellular carcinoma and correlates cancer prognosis.

Authors:  Yue Li; You Li; Yao Chen; Qian Xie; Ningning Dong; Yanjun Gao; Huan Deng; Chunhua Lu; Suihai Wang
Journal:  Cancer Cell Int       Date:  2017-11-07       Impact factor: 5.722

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.